stockrowVericel Corporation
VCEL Healthcare Biotechnology
Vericel Corporation’s revenue for fiscal 2025 (year ended December 2025) was $276.3 million, up 16.5% from fiscal 2024.
- Revenue
- +26.5%
- EPS
- +180.0%
- Free cash flow
- −19.4%
Quarter to September 2026, against a year earlier
Follow VCEL
Alert me
Vericel Corporation (VCEL) Operating margin
Vericel Corporation's operating margin over the twelve months to 30 September 2026 was 8.32%, up 4.3 percentage points from fiscal 2025 (4.00%). Over the past ten years it has ranged from −35.4% (fiscal 2016) to 4.00% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 4.00% | 2.10 |
| FY2024 | 1.90% | 5.17 |
| FY2023 | −3.27% | 7.11 |
| FY2022 | −10.4% | (5.35) |
| FY2021 | −5.03% | (6.94) |
| FY2020 | 1.91% | 11.46 |
| FY2019 | −9.55% | (5.25) |
| FY2018 | −4.30% | 19.14 |
| FY2017 | −23.4% | 11.95 |
| FY2016 | −35.4% | (2.81) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 14.3% | 13.71 |
| Jun 2026 | 0.56% | 12.35 |
| Mar 2026 | −11.8% | (35.91) |
| Dec 2025 | 24.1% | 19.01 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc compare | 46.5% |
| AUPH Aurinia Pharmaceuticals Inc compare | 44.8% |
| VCEL Vericel Corporation | 8.32% |
| IMNM Immunome, Inc. compare | 0.00% |
| VERA Vera Therapeutics, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| PVLA Palvella Therapeutics, Inc. compare | 0.00% |
| CLDX Celldex Therapeutics, Inc. compare | −36,733.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on VCEL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement